These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6886996)

  • 1. High-yield synthesis of warfarin and its phenolic metabolites: new compounds.
    Bush E; Trager WF
    J Pharm Sci; 1983 Jul; 72(7):830-1. PubMed ID: 6886996
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure of (+-)-6-methyl-6,12-methano-6H,12H,13H-[1]benzopyran[4,3-d] [1,3]benzodioxocin-13-one.
    Ruggiero G; Valente EJ; Eggleston DS
    Acta Crystallogr C; 1989 Aug; 45 ( Pt 8)():1182-4. PubMed ID: 2604944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of S-oxidation on the anticoagulant action of warfarin thioanalogs].
    Rehse K; Rüther D
    Arch Pharm (Weinheim); 1984 Feb; 317(2):163-7. PubMed ID: 6732444
    [No Abstract]   [Full Text] [Related]  

  • 4. New acylated 1,2,4-triazoles as antiviral agents.
    Somorai T; Szilágyi G; Reiter J; Pongó L; Láng T; Toldy L; Horváth S
    Arch Pharm (Weinheim); 1986 Mar; 319(3):238-42. PubMed ID: 3718178
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of the biological performance of oral anticoagulant drugs. 1. Warfarin.
    Ammar HO; Ghorab M; el-Nahhas SA; Makram TS
    Pharmazie; 1997 Aug; 52(8):627-31. PubMed ID: 9292918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new entry to Pd-H chemistry: catalytic asymmetric conjugate reduction of enones with EtOH and a highly enantioselective synthesis of warfarin.
    Tsuchiya Y; Hamashima Y; Sodeoka M
    Org Lett; 2006 Oct; 8(21):4851-4. PubMed ID: 17020319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new warfarin metabolite: structure and function.
    Fasco MJ; Dymerski PP; Wos JD; Kaminsky LS
    J Med Chem; 1978 Oct; 21(10):1054-9. PubMed ID: 722713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLC determination of warfarin in human plasma.
    Kaiser DG; Martin RS
    J Pharm Sci; 1974 Oct; 63(10):1579-81. PubMed ID: 4436791
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vivo strategy to counteract post-administration anticoagulant activity of azido-Warfarin.
    Ursuegui S; Recher M; Krężel W; Wagner A
    Nat Commun; 2017 May; 8():15242. PubMed ID: 28524847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations.
    Lawrence RF; Rettie AE; Eddy AC; Trager WF
    Chirality; 1990; 2(2):96-105. PubMed ID: 2400642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azidowarfarin as photoaffinity probe of cytochromes P450.
    Kaminsky LS; Dunbar D; Lawson W
    Methods Enzymol; 1991; 206():57-63. PubMed ID: 1784243
    [No Abstract]   [Full Text] [Related]  

  • 12. Asymmetric synthesis of warfarin and its analogs catalyzed by C
    Kochetkov SV; Kucherenko AS; Zlotin SG
    Org Biomol Chem; 2018 Sep; 16(35):6423-6429. PubMed ID: 30047554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of warfarin and its metabolites by reversed-phase ion-pair liquid chromatography with fluorescence detection.
    Wong YW; Davis PJ
    J Chromatogr; 1989 May; 469():281-91. PubMed ID: 2768373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of iodo-3-aminophenols].
    Wunderer H
    Arch Pharm (Weinheim); 1973 May; 306(5):371-80. PubMed ID: 4721598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis of polyphenolic aminocarboxylic acid derivatives as radio-actinides mobilization agents].
    Du J; Sun MZ; Xue F
    Yao Xue Xue Bao; 1989; 24(9):711-4. PubMed ID: 2618722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution.
    Stokker GE; Deana AA; deSolms SJ; Schultz EM; Smith RL; Cragoe EJ; Baer JE; Ludden CT; Russo HF; Scriabine A; Sweet CS; Watson LS
    J Med Chem; 1980 Dec; 23(12):1414-27. PubMed ID: 7452697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate probes for the mechanism of aromatic hydroxylation catalyzed by cytochrome P-450: selectively deuterated analogues of warfarin.
    Bush ED; Trager WF
    J Med Chem; 1985 Aug; 28(8):992-6. PubMed ID: 4020838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin metabolism in man: identification of metabolites in urine.
    Lewis RJ; Trager WF
    J Clin Invest; 1970 May; 49(5):907-13. PubMed ID: 5441544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly enantioselective synthesis of warfarin and its analogs catalysed by primary amine-phosphinamide bifunctional catalysts.
    Dong J; Du DM
    Org Biomol Chem; 2012 Oct; 10(40):8125-31. PubMed ID: 22956019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.